- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期的强势行情可能结束，投资者及时短线卖出、离场观望为宜。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有315家主力机构披露2026-06-30报告期持股数据，持仓量总计6.31亿股，占流通A股45.82%
- 波段诊断：
-
技术面诊股
诊断结果：7.6技术面打败了90%的股票
技术面评分前10的股票
近期的平均成本为16.07元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为16.07元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"16.07","date":1793865981,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，跑赢行业平均水平。
[{"date":"2026.11.06","stock":"-0.37","trade":"-0.80","ind":"-2.57"},{"date":"2026.11.05","stock":"0.37","trade":"1.29","ind":"1.19"},{"date":"2026.11.04","stock":"0.63","trade":"0.85","ind":"4.22"},{"date":"2026.11.03","stock":"1.27","trade":"0.44","ind":"-1.21"},{"date":"2026.11.02","stock":"1.74","trade":"1.93","ind":"1.63"},{"date":"2026.10.30","stock":"1.57","trade":"-0.03","ind":"-2.73"},{"date":"2026.10.29","stock":"-1.17","trade":"-1.62","ind":"-2.92"},{"date":"2026.10.28","stock":"-0.84","trade":"0.86","ind":"2.02"},{"date":"2026.10.27","stock":"-1.95","trade":"-2.32","ind":"-2.50"},{"date":"2026.10.26","stock":"1.34","trade":"0.48","ind":"-1.19"},{"date":"2026.10.23","stock":"3.57","trade":"0.88","ind":"2.79"},{"date":"2026.10.22","stock":"-1.24","trade":"-2.52","ind":"-2.96"},{"date":"2026.10.21","stock":"-0.26","trade":"-0.15","ind":"-0.82"},{"date":"2026.10.20","stock":"-0.13","trade":"-0.28","ind":"-0.14"},{"date":"2026.10.19","stock":"1.99","trade":"0.26","ind":"0.13"},{"date":"2026.10.16","stock":"0.33","trade":"-0.12","ind":"-0.12"},{"date":"2026.10.15","stock":"-0.40","trade":"-1.40","ind":"-2.43"},{"date":"2026.10.14","stock":"0.00","trade":"-0.46","ind":"-1.97"},{"date":"2026.10.13","stock":"-1.12","trade":"-0.13","ind":"-0.25"},{"date":"2026.10.12","stock":"-1.87","trade":"-1.56","ind":"-2.03"},{"date":"2026.10.09","stock":"0.91","trade":"2.04","ind":"0.17"}]
以岭药业,深证成指,中药指数
压力支撑
该股压力位为15.99元，支撑位为15.81元。
[{"text":"\u538b\u529b\u4f4d","value":"15.99","date":1793894400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"15.81","date":1793894400,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.9资金面打败了51%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：11月06日 20:30
| 机构今日流向(万元) | -548.61 | 机构5日流向(万元) | 2633.26 |
| 机构10日流向(万元) | 1160.99 | 机构20日流向(万元) | -3148.34 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少1732.78万股，其中基金净减仓36家，主力净减仓18家，请投资者中长期谨慎为宜。
截止2026-06-30，共315家主力机构（基金312家，其他资管计划1家，一般法人2家），持仓量总计63054.22万股，占流通A股45.82%
其中，基金持仓与2025-12-31相比：
增仓：83家 ，增持 1401.19万股
减仓：119家 ，减持 1878.11万股
新出现在主力名单中：100家 ，持有841.38万股
从主力名单中消失：118家 ，原持有1352.69万股
其中，基金持仓与2025-12-31相比：
增仓：83家 ，增持 1401.19万股
减仓：119家 ，减持 1878.11万股
新出现在主力名单中：100家 ，持有841.38万股
从主力名单中消失：118家 ，原持有1352.69万股
消息面诊股
诊断结果：5.5消息面打败了21%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 老品种稳盘、新单品破局，多家中药药企前三季度营收净
2026-11-06 - 又一个中药1.1类创新药获批上市！以岭药业中药创新
2026-11-06 - 以岭药业：11月5日获融资买入1865.41万元
2026-11-06 - 华虹宏力、百济神州业绩大增，天赐材料锁定电解液长单
2026-11-05 - 刚刚！以岭药业儿科中药1类新药获批了
2026-11-05 - 以岭药业：中药创新药小儿连花感冒颗粒获药品注册证书
2026-11-05 - 以岭药业：11月4日获融资买入1969.30万元
2026-11-05 - 收现比大于1、现金流增25.86%，以岭药业三季报
2026-11-04 - 专家共论络病理论创新价值 探索中医药高质量发展路径
2026-11-04 - 中药行业三季报观察：行业增长收窄盈利承压显著 消费
2026-11-04
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-09-12 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-29 |
| 一般消息 | 募资投向 | 2026-06-05 | |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-28 |
| 利好 | 分红转增 | 10派5元(含税) | 2026-04-28 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-28 |
| 利好 | 业绩预告 | 预计扭亏 | 2026-01-23 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-20 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：7.1行业面打败了94%的股票
中药行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2026.11.06","price":"-2.57","value":"-0.80"},{"date":"2026.11.05","price":"1.19","value":"1.29"},{"date":"2026.11.04","price":"4.22","value":"0.85"},{"date":"2026.11.03","price":"-1.21","value":"0.44"},{"date":"2026.11.02","price":"1.63","value":"1.93"},{"date":"2026.10.30","price":"-2.73","value":"-0.03"},{"date":"2026.10.29","price":"-2.92","value":"-1.62"},{"date":"2026.10.28","price":"2.02","value":"0.86"},{"date":"2026.10.27","price":"-2.50","value":"-2.32"},{"date":"2026.10.26","price":"-1.19","value":"0.48"},{"date":"2026.10.23","price":"2.79","value":"0.88"},{"date":"2026.10.22","price":"-2.96","value":"-2.52"},{"date":"2026.10.21","price":"-0.82","value":"-0.15"},{"date":"2026.10.20","price":"-0.14","value":"-0.28"},{"date":"2026.10.19","price":"0.13","value":"0.26"},{"date":"2026.10.16","price":"-0.12","value":"-0.12"},{"date":"2026.10.15","price":"-2.43","value":"-1.40"},{"date":"2026.10.14","price":"-1.97","value":"-0.46"},{"date":"2026.10.13","price":"-0.25","value":"-0.13"},{"date":"2026.10.12","price":"-2.03","value":"-1.56"},{"date":"2026.10.09","price":"0.17","value":"2.04"}]
深证成指,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 桂林三金 | 47.37% | 21.50% | 7.1分 |
| 2 | 羚锐制药 | 21.41% | 8.50% | 7.5分 |
| 3 | 达仁堂 | 17.65% | 4.52% | 6.5分 |
| 4 | 片仔癀 | 14.53% | 5.76% | 6.4分 |
| 5 | 济川药业 | 9.66% | 6.13% | 7.0分 |
| 6 | 马应龙 | 9.15% | 3.26% | 7.1分 |
| 8 | 云南白药 | 7.28% | 2.66% | 7.5分 |
| 10 | 昆药集团 | 5.98% | 2.19% | 5.9分 |
| 12 | 步长制药 | 5.37% | 2.93% | 6.9分 |
| 14 | 维康药业 | 4.68% | 14.03% | 6.3分 |
| 16 | 天士力 | 3.08% | 4.12% | 6.5分 |
| 18 | 健民集团 | 1.56% | 4.68% | 6.6分 |
| 20 | 信邦制药 | 1.33% | -0.65% | 6.2分 |
| 22 | 康美药业 | -0.74% | 4.69% | 6.0分 |
| 24 | 奇正藏药 | -0.97% | 3.31% | 5.2分 |
| 26 | 众生药业 | -2.35% | 13.03% | 5.7分 |
| 28 | 红日药业 | -3.01% | 4.89% | 5.7分 |
| 30 | 亚宝药业 | -3.11% | -4.33% | 6.2分 |
| 32 | 康恩贝 | -3.40% | 1.19% | 6.1分 |
| 34 | 新光药业 | -4.02% | 4.75% | 4.6分 |
| 36 | 盘龙药业 | -5.43% | 4.02% | 5.2分 |
| 38 | 九芝堂 | -5.84% | 3.07% | 6.2分 |
| 40 | *ST香雪 | -7.47% | 12.39% | 5.7分 |
| 42 | ST葫芦娃 | -7.75% | 3.28% | 4.5分 |
| 44 | - | -8.94% | 2.64% | 分 |
| 46 | ST嘉应 | -10.14% | 4.25% | 4.7分 |
| 48 | 上海凯宝 | -10.58% | 2.55% | 4.8分 |
| 50 | 新天药业 | -11.70% | 2.44% | 5.3分 |
| 52 | 益佰制药 | -13.04% | 0.31% | 4.1分 |
| 54 | 三力制药 | -13.63% | 2.17% | 4.9分 |
| 56 | 康惠股份 | -14.26% | 2.50% | 4.8分 |
| 58 | 古汉医药 | -14.38% | 1.55% | 4.9分 |
| 60 | 华森制药 | -16.19% | -2.04% | 5.3分 |
| 62 | 沃华医药 | -18.50% | 2.92% | 5.7分 |
| 64 | 粤万年青 | -20.05% | 3.79% | 4.8分 |
| 66 | 天目药业 | -21.86% | 4.19% | 4.7分 |
| 68 | 精华制药 | -24.89% | 1.46% | 4.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 12/110 ， 20/110。
[{"date":"2026-09-30","value":"9.86","vol":"4.23"},{"date":"2026-06-30","value":"6.92","vol":"3.25"},{"date":"2026-03-31","value":"3.65","vol":"2.21"},{"date":"2025-12-31","value":"12.13","vol":"-2.33"},{"date":"2025-09-30","value":"9.56","vol":"4.80"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
9.86 | 6.92 | 3.65 | 12.13 | 9.56 |
| 行业(%) | 4.23 | 3.25 | 2.21 | -2.33 | 4.80 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"64.05","vol":"52.92"},{"date":"2026-06-30","value":"62.99","vol":"53.70"},{"date":"2026-03-31","value":"60.05","vol":"55.05"},{"date":"2025-12-31","value":"64.28","vol":"52.85"},{"date":"2025-09-30","value":"60.53","vol":"53.29"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
64.05 | 62.99 | 60.05 | 64.28 | 60.53 |
| 行业(%) | 52.92 | 53.70 | 55.05 | 52.85 | 53.29 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 17/110 ， 20/110。
[{"date":"2026-09-30","value":"1.72","vol":"-8.01"},{"date":"2026-06-30","value":"0.86","vol":"-9.08"},{"date":"2026-03-31","value":"3.46","vol":"-5.58"},{"date":"2025-12-31","value":"20.24","vol":"-6.76"},{"date":"2025-09-30","value":"-7.82","vol":"-7.84"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
1.72 | 0.86 | 3.46 | 20.24 | -7.82 |
| 行业(%) | -8.01 | -9.08 | -5.58 | -6.76 | -7.84 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"9.55","vol":"-22.29"},{"date":"2026-06-30","value":"13.28","vol":"-101.51"},{"date":"2026-03-31","value":"25.43","vol":"1.06"},{"date":"2025-12-31","value":"277.56","vol":"-80.25"},{"date":"2025-09-30","value":"80.33","vol":"-2.78"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
9.55 | 13.28 | 25.43 | 277.56 | 80.33 |
| 行业(%) | -22.29 | -101.51 | 1.06 | -80.25 | -2.78 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 13/110 ， 38/110。
[{"date":"2026-09-30","value":"0.43","vol":"0.33"},{"date":"2026-06-30","value":"0.29","vol":"0.22"},{"date":"2026-03-31","value":"0.18","vol":"0.12"},{"date":"2025-12-31","value":"0.58","vol":"0.47"},{"date":"2025-09-30","value":"0.43","vol":"0.35"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.43 | 0.29 | 0.18 | 0.58 | 0.43 |
| 行业(次) | 0.33 | 0.22 | 0.12 | 0.47 | 0.35 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"1.45","vol":"1.72"},{"date":"2026-06-30","value":"0.98","vol":"1.14"},{"date":"2026-03-31","value":"0.69","vol":"0.59"},{"date":"2025-12-31","value":"1.73","vol":"2.34"},{"date":"2025-09-30","value":"1.35","vol":"1.72"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.45 | 0.98 | 0.69 | 1.73 | 1.35 |
| 行业(次) | 1.72 | 1.14 | 0.59 | 2.34 | 1.72 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-09-30","value":"22.65","vol":"13.37"},{"date":"2026-06-30","value":"34.81","vol":"20.65"},{"date":"2026-03-31","value":"25.03","vol":"5.83"},{"date":"2025-12-31","value":"25.38","vol":"30.77"},{"date":"2025-09-30","value":"24.42","vol":"10.53"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 22.65 | 34.81 | 25.03 | 25.38 | 24.42 |
| 行业 | 13.37 | 20.65 | 5.83 | 30.77 | 10.53 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"","vol":"0.00"},{"date":"2026-06-30","value":"0.32","vol":"0.88"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.39","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.32 | - | 0.39 | - |
| 行业 | 0.00 | 0.88 | 0.00 | 1.00 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 18/110 ， 39/110。
[{"date":"2026-09-30","value":"2.48","vol":"3.18"},{"date":"2026-06-30","value":"2.20","vol":"3.10"},{"date":"2026-03-31","value":"2.50","vol":"2.97"},{"date":"2025-12-31","value":"2.36","vol":"2.94"},{"date":"2025-09-30","value":"1.85","vol":"3.09"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.48 | 2.20 | 2.50 | 2.36 | 1.85 |
| 行业 | 3.18 | 3.10 | 2.97 | 2.94 | 3.09 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"1.83","vol":"2.39"},{"date":"2026-06-30","value":"1.54","vol":"2.34"},{"date":"2026-03-31","value":"1.87","vol":"2.23"},{"date":"2025-12-31","value":"1.60","vol":"2.15"},{"date":"2025-09-30","value":"1.24","vol":"2.24"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.83 | 1.54 | 1.87 | 1.60 | 1.24 |
| 行业 | 2.39 | 2.34 | 2.23 | 2.15 | 2.24 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 45/110 ， 46/110。
[{"date":"2026-09-30","value":"20.57","vol":"31.42"},{"date":"2026-06-30","value":"22.03","vol":"32.07"},{"date":"2026-03-31","value":"19.66","vol":"31.94"},{"date":"2025-12-31","value":"19.69","vol":"32.43"},{"date":"2025-09-30","value":"24.77","vol":"31.59"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
20.57 | 22.03 | 19.66 | 19.69 | 24.77 |
| 行业(%) | 31.42 | 32.07 | 31.94 | 32.43 | 31.59 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"0.26","vol":"0.67"},{"date":"2026-06-30","value":"0.28","vol":"0.68"},{"date":"2026-03-31","value":"0.24","vol":"0.66"},{"date":"2025-12-31","value":"0.25","vol":"0.67"},{"date":"2025-09-30","value":"0.33","vol":"0.76"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.26 | 0.28 | 0.24 | 0.25 | 0.33 |
| 行业(%) | 0.67 | 0.68 | 0.66 | 0.67 | 0.76 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 湘财证券 | 2026-11-04 | 买入 | |
| 申万宏源 | 2026-11-02 | 增持 | |
| 华泰证券 | 2026-10-30 | 买入 | 买入 |
| 中信建投证券 | 2026-09-06 | 买入 | |
| 长城证券 | 2026-09-04 | 买入 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"23.63","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"13.52","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-7.25","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"12.86","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"14.88","blueLineValue":"0.89","type":"YC"}]